Annual Operating Expenses
$7.28 M
-$3.02 M-29.31%
31 December 2023
Summary:
Titan Pharmaceuticals annual total operating expenses is currently $7.28 million, with the most recent change of -$3.02 million (-29.31%) on 31 December 2023. During the last 3 years, it has fallen by -$4.44 million (-37.89%). TTNP annual operating expenses is now -79.14% below its all-time high of $34.90 million, reached on 31 December 2002.TTNP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$2.07 M
+$1.01 M+95.11%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly total operating expenses is currently $2.07 million, with the most recent change of +$1.01 million (+95.11%) on 30 June 2024. Over the past year, it has increased by +$13.00 thousand (+0.63%). TTNP quarterly operating expenses is now -84.17% below its all-time high of $13.10 million, reached on 31 March 1997.TTNP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | +0.6% |
| 3 y3 years | -37.9% | +6.5% |
| 5 y5 years | -49.3% | -46.6% |
TTNP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.9% | at low | -22.1% | +95.1% |
| 5 y | 5 years | -49.3% | at low | -46.6% | +139.5% |
| alltime | all time | -79.1% | +23.5% | -84.2% | +139.5% |
Titan Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $2.07 M(+95.1%) |
| Mar 2024 | - | $1.06 M(-45.0%) |
| Dec 2023 | $7.28 M(-29.3%) | $1.93 M(-6.3%) |
| Sept 2023 | - | $2.06 M(+29.7%) |
| June 2023 | - | $1.59 M(-6.4%) |
| Mar 2023 | - | $1.70 M(-36.3%) |
| Dec 2022 | $10.29 M(+9.5%) | $2.66 M(+0.6%) |
| Sept 2022 | - | $2.65 M(+8.3%) |
| June 2022 | - | $2.44 M(-3.8%) |
| Mar 2022 | - | $2.54 M(+2.0%) |
| Dec 2021 | $9.40 M(-19.7%) | $2.49 M(+28.0%) |
| Sept 2021 | - | $1.95 M(-16.3%) |
| June 2021 | - | $2.33 M(-11.7%) |
| Mar 2021 | - | $2.63 M(+11.1%) |
| Dec 2020 | $11.72 M(+11.8%) | $2.37 M(+98.2%) |
| Sept 2020 | - | $1.20 M(-28.1%) |
| June 2020 | - | $1.66 M(-15.8%) |
| Mar 2020 | - | $1.98 M(-137.7%) |
| Dec 2019 | $10.48 M(-26.9%) | -$5.25 M(-235.0%) |
| Sept 2019 | - | $3.88 M(-21.4%) |
| June 2019 | - | $4.94 M(+7.1%) |
| Mar 2019 | - | $4.61 M(+31.5%) |
| Dec 2018 | $14.34 M(-2.5%) | $3.51 M(+2.4%) |
| Sept 2018 | - | $3.42 M(+5.8%) |
| June 2018 | - | $3.24 M(-6.7%) |
| Mar 2018 | - | $3.47 M(+1.1%) |
| Dec 2017 | $14.72 M(+37.3%) | $3.43 M(-16.5%) |
| Sept 2017 | - | $4.11 M(+11.1%) |
| June 2017 | - | $3.70 M(+6.4%) |
| Mar 2017 | - | $3.48 M(+5.7%) |
| Dec 2016 | $10.72 M(+27.2%) | $3.29 M(+24.5%) |
| Sept 2016 | - | $2.64 M(-10.7%) |
| June 2016 | - | $2.96 M(+61.7%) |
| Mar 2016 | - | $1.83 M(-18.6%) |
| Dec 2015 | $8.43 M(+18.4%) | $2.25 M(+24.9%) |
| Sept 2015 | - | $1.80 M(-2.7%) |
| June 2015 | - | $1.85 M(-26.7%) |
| Mar 2015 | - | $2.53 M(+16.7%) |
| Dec 2014 | $7.12 M(-37.4%) | $2.17 M(+31.3%) |
| Sept 2014 | - | $1.65 M(+12.9%) |
| June 2014 | - | $1.46 M(-20.8%) |
| Mar 2014 | - | $1.84 M(+18.8%) |
| Dec 2013 | $11.37 M(-26.6%) | $1.55 M(-33.2%) |
| Sept 2013 | - | $2.33 M(-6.6%) |
| June 2013 | - | $2.49 M(-50.2%) |
| Mar 2013 | - | $5.00 M(+35.2%) |
| Dec 2012 | $15.49 M(+6.3%) | $3.70 M(-4.8%) |
| Sept 2012 | - | $3.88 M(+25.4%) |
| June 2012 | - | $3.10 M(-35.5%) |
| Mar 2012 | - | $4.80 M(+120.4%) |
| Dec 2011 | $14.57 M(-9.6%) | $2.18 M(-26.6%) |
| Sept 2011 | - | $2.97 M(-39.3%) |
| June 2011 | - | $4.89 M(+8.0%) |
| Mar 2011 | - | $4.53 M(-32.5%) |
| Dec 2010 | $16.12 M | $6.71 M(+79.7%) |
| Sept 2010 | - | $3.73 M(+21.7%) |
| June 2010 | - | $3.07 M(+17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $2.60 M(+82.2%) |
| Dec 2009 | $5.89 M(-68.1%) | $1.43 M(-9.8%) |
| Sept 2009 | - | $1.58 M(-10.4%) |
| June 2009 | - | $1.77 M(+59.4%) |
| Mar 2009 | - | $1.11 M(-81.6%) |
| Sept 2008 | - | $6.02 M(-23.5%) |
| June 2008 | - | $7.86 M(+30.7%) |
| Mar 2008 | - | $6.01 M(-5.7%) |
| Dec 2007 | $18.46 M(+12.0%) | $6.38 M(+39.9%) |
| Sept 2007 | - | $4.56 M(+13.3%) |
| June 2007 | - | $4.03 M(+15.2%) |
| Mar 2007 | - | $3.49 M(0.0%) |
| Dec 2006 | $16.48 M(-28.8%) | $3.49 M(-23.2%) |
| Sept 2006 | - | $4.55 M(+25.9%) |
| June 2006 | - | $3.62 M(-25.0%) |
| Mar 2006 | - | $4.82 M(+12.7%) |
| Dec 2005 | $23.14 M(-9.8%) | $4.28 M(-34.6%) |
| Sept 2005 | - | $6.54 M(+11.6%) |
| June 2005 | - | $5.86 M(-9.3%) |
| Mar 2005 | - | $6.46 M(-10.6%) |
| Dec 2004 | $25.65 M(-6.3%) | $7.23 M(+16.1%) |
| Sept 2004 | - | $6.22 M(+8.9%) |
| June 2004 | - | $5.72 M(-11.8%) |
| Mar 2004 | - | $6.48 M(-5.4%) |
| Dec 2003 | $27.37 M(-21.6%) | $6.85 M(+5.4%) |
| Sept 2003 | - | $6.50 M(-7.0%) |
| June 2003 | - | $6.99 M(-0.5%) |
| Mar 2003 | - | $7.03 M(-25.1%) |
| Dec 2002 | $34.90 M(+21.5%) | $9.37 M(+10.1%) |
| Sept 2002 | - | $8.52 M(+2.5%) |
| June 2002 | - | $8.31 M(-4.4%) |
| Mar 2002 | - | $8.70 M(+2.1%) |
| Dec 2001 | $28.72 M(+36.7%) | $8.52 M(+20.5%) |
| Sept 2001 | - | $7.07 M(+7.9%) |
| June 2001 | - | $6.55 M(-1.4%) |
| Mar 2001 | - | $6.65 M(+7.3%) |
| Dec 2000 | $21.01 M(+66.7%) | $6.20 M(+6.4%) |
| Sept 2000 | - | $5.82 M(+43.6%) |
| June 2000 | - | $4.05 M(-18.7%) |
| Mar 2000 | - | $4.99 M(+38.5%) |
| Dec 1999 | $12.60 M(+6.8%) | $3.60 M(+44.0%) |
| Sept 1999 | - | $2.50 M(-24.2%) |
| June 1999 | - | $3.30 M(+10.0%) |
| Mar 1999 | - | $3.00 M(-14.3%) |
| Dec 1998 | $11.80 M(-54.1%) | $3.50 M(+16.7%) |
| Sept 1998 | - | $3.00 M(+20.0%) |
| June 1998 | - | $2.50 M(-10.7%) |
| Mar 1998 | - | $2.80 M(-33.3%) |
| Dec 1997 | $25.70 M(+125.4%) | $4.20 M(+5.0%) |
| Sept 1997 | - | $4.00 M(-7.0%) |
| June 1997 | - | $4.30 M(-67.2%) |
| Mar 1997 | - | $13.10 M(+219.5%) |
| Dec 1996 | $11.40 M(+16.3%) | $4.10 M(+51.9%) |
| Sept 1996 | - | $2.70 M(0.0%) |
| June 1996 | - | $2.70 M(+50.0%) |
| Mar 1996 | - | $1.80 M |
| Dec 1995 | $9.80 M | - |
FAQ
- What is Titan Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual operating expenses year-on-year change?
- What is Titan Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly operating expenses year-on-year change?
What is Titan Pharmaceuticals annual total operating expenses?
The current annual operating expenses of TTNP is $7.28 M
What is the all time high annual operating expenses for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total operating expenses is $34.90 M
What is Titan Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, TTNP annual total operating expenses has changed by -$3.02 M (-29.31%)
What is Titan Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of TTNP is $2.07 M
What is the all time high quarterly operating expenses for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total operating expenses is $13.10 M
What is Titan Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, TTNP quarterly total operating expenses has changed by +$13.00 K (+0.63%)